Lymphocytic
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia (NCT03759184) | National Cancer Institute (NCI) | 2019-07-11 |
| A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer (NCT01149668) | Pharmacyclics LLC. | 2010-06-01 |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia (NCT00077922) | National Cancer Institute (NCI) | 2004-02-29 |
Track Lymphocytic automatically
Every clearance here is in the API, with alerts when new ones post.